Digital Pathology Market Driven by AI Integration and Rising Demand for Remote Diagnostics | F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Olympus Corporation

The Global Digital Pathology Market reached USD 0.9 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 1.7 billion by 2031. The global digital pathology market is expected to exhibit a CAGR of 8.7% during the forecast peri

Digital Pathology Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With the integration of AI in pathology, rising adoption of whole-slide imaging, and demand for remote diagnostics, the report delivers strategic insights to support stakeholders in digital diagnostics transformation from 2025 to 2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/digital-pathology-market?ophp

Digital Pathology involves scanning traditional glass slides and analyzing digital images using AI and software. The market is gaining momentum due to growing adoption in cancer diagnostics, telepathology, and academic research. Key drivers include lab workflow automation, remote consultation needs, and regulatory approvals for digital solutions.

Digital Pathology Market Competitors Overview:

F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Olympus Corporation, Leica Biosystems Nussloch GmbH (Danaher Corporation), Hamamatsu Photonics, Inc., Mikroscan Technologies, Inc., Inspirata, Inc. (Fujifilm), Visiopharm A/S, Huron Technologies International Inc., and ContextVision AB.

Important Industry Updates of 2025:

✅ February 10, 2025 - FDA granted 510(k) clearance to Ibex Medical Analytics' AI-powered prostate cancer detection software, Prostate Detect, for analyzing tissue biopsies. In validation studies, it achieved a 99.6% positive predictive value, and identified cancer cases that pathologists missed unaided.

✅ March 5, 2025 - Epredia's E1000 Dx digital pathology scanner and image viewer received FDA 510(k) clearance. The system supports high-throughput processing (up to 1,500 slides per day), integrated quality-control scanning, and vendor-agnostic interoperability in clinical diagnostic labs .

✅ June 24-26, 2025 - PathPresenter's Clinical Viewer received FDA 510(k) clearance for primary diagnosis usage. Part of PathPresenter's full image management system (IMS), it enables LIS integration, case tracking, multi-user collaboration, and remote second opinions.

✅ June 30, 2025 - PathAI's AISight® Dx platform was cleared by the FDA for use in clinical primary diagnosis. This cloud-native pathology image management system also received a Predetermined Change Control Plan (PCCP) allowing future hardware and software updates without re-filing 510(k)s, accelerating iteration cycles

Methodology and Scope

The Digital Pathology Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/digital-pathology-market?ophp

Digital Pathology Market Segments Overview:

∎ By Product (Software, Scanners, Storage Systems, Communication Systems)
∎ By Application (Drug Discovery, Teleconsultation, Diagnosis, Training & Education)
∎ By Type (Human Pathology, Veterinary Pathology)
∎ By Technology (Whole Slide Imaging, Telepathology(Static Telepathology, Dynamic Telepathology))
∎ By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Research & Academic Institutes, Hospital laboratories)

The whole slide imaging (WSI) segment holds the largest share, as it enables high-resolution digitization of pathology slides, supporting remote diagnostics and AI analysis.

Regional Overview for Digital Pathology Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

North America leads the digital pathology market, driven by AI-powered diagnostics, large-scale implementation in labs, and favorable reimbursement structures. Asia Pacific is the fastest growing region as demand for cancer diagnostics grows and digitization of pathology labs accelerates.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=digital-pathology-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the «Keyword» market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the «Keyword» market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.